MTD METTLER TOLEDO INTERNATIONAL INC/
Laboratory Analytical Instruments · NYSE · SEC CIK 1037646 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.5%
TTM net income YoY11.8%
TTM EPS YoY15.0%
Revenue 3-yr CAGR2.4%
Net income 3-yr CAGR5.6%
Margins
Gross margin60.4%
Operating margin—
Net margin22.2%
FCF margin20.7%
EBITDA margin—
Returns
ROE—
ROA25.9%
ROIC (approx.)—
Asset turnover1.16x
Leverage & solvency
Liabilities / assets97.9%
Debt / equity26.06x
Current ratio1.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.05x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q32026-09-30 | 2026-06-302026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2024Q22025-06-30 | 2024Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.09B | $1.03B | $947.13M | $1.13B | $1.03B | $983.22M | $883.74M | $1.05B |
| Gross profit | $654.22M | $650.22M | $555.82M | $675.43M | $609.46M | $579.88M | $525.88M | $639.32M |
| R&D expense | $53.61M | $52.99M | $51.27M | $52.60M | $51.14M | $49.28M | $46.35M | $50.05M |
| SG&A expense | $267.16M | $263.33M | $258.33M | $259.83M | $248.39M | $247.30M | $242.80M | $237.34M |
| Interest expense | $15.68M | $17.25M | $17.01M | $17.39M | $17.70M | $16.78M | $16.65M | $17.85M |
| Pretax income | $300.20M | $289.40M | $209.66M | $329.07M | $269.24M | $248.66M | $201.94M | $314.55M |
| Income tax | $54.25M | $56.50M | $40.20M | $43.31M | $51.74M | $46.31M | $38.35M | $62.25M |
| Net income | $245.95M | $232.90M | $169.45M | $285.76M | $217.49M | $202.35M | $163.59M | $252.30M |
| EPS (basic) | 12.32 | 11.57 | 8.35 | — | 10.60 | 9.78 | 7.84 | — |
| EPS (diluted) | 12.29 | 11.55 | 8.33 | — | 10.57 | 9.76 | 7.81 | — |
| Weighted avg. shares (diluted) | 20.02M | 20.17M | 20.34M | — | 20.57M | 20.74M | 20.95M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $52.24M | $51.38M | $60.57M | $66.89M | $69.06M | $61.83M | $64.29M | $59.36M |
| Receivables | $733.19M | $731.48M | $708.21M | $778.24M | $687.26M | $681.60M | $638.39M | $687.11M |
| Inventory | $439.66M | $411.56M | $404.83M | $387.23M | $401.81M | $388.08M | $358.79M | $342.27M |
| Current assets | $1.38B | $1.35B | $1.33B | $1.36B | $1.28B | $1.24B | $1.16B | $1.19B |
| PP&E, net | $831.34M | $831.94M | $830.33M | $845.64M | $817.74M | $817.42M | $778.00M | $770.28M |
| Goodwill | $735.43M | $735.21M | $736.87M | $739.23M | $731.21M | $684.12M | $673.25M | $668.91M |
| Intangibles | $258.99M | $266.26M | $273.76M | $278.91M | $278.35M | $253.53M | $251.80M | $257.14M |
| Total assets | $3.70B | $3.67B | $3.67B | $3.71B | $3.52B | $3.40B | $3.23B | $3.24B |
| Current liabilities | $1.25B | $1.20B | $1.11B | $1.20B | $1.19B | $1.11B | $1.15B | $1.17B |
| Short-term debt | $60.24M | $67.29M | — | $63.93M | $63.61M | $60.19M | — | $182.62M |
| Long-term debt | $1.96B | $2.04B | $2.16B | $2.09B | $2.15B | $2.12B | $1.89B | $1.83B |
| Total debt | $2.02B | $2.11B | $2.16B | $2.15B | $2.21B | $2.18B | $1.89B | $2.01B |
| Total liabilities | $3.62B | $3.66B | $3.71B | $3.74B | $3.77B | $3.66B | $3.42B | $3.37B |
| Shareholders' equity | $77.66M | $12.82M | -$41.88M | -$23.64M | -$249.20M | -$258.79M | -$181.98M | -$126.89M |
| Net debt | $1.97B | $2.06B | $2.10B | $2.09B | $2.14B | $2.12B | $1.83B | $1.95B |
| Shares outstanding | 21.68M | 21.68M | 21.36M | 22.14M | 21.68M | 21.68M | 21.36M | 20.95M |
| Cash flow statement | ||||||||
| Operating cash flow | $308.57M | $310.42M | $139.79M | $225.59M | $299.37M | $236.37M | $194.45M | $266.19M |
| Capital expenditure | $27.09M | $27.79M | $17.41M | $41.50M | $24.49M | $23.88M | $17.25M | $41.28M |
| Free cash flow | $281.48M | $282.62M | $122.38M | $184.08M | $274.88M | $212.49M | $177.19M | $224.91M |
| Investing cash flow | -$10.57M | -$1.94M | -$31.35M | -$40.41M | -$98.91M | -$47.65M | -$6.91M | -$51.05M |
| Financing cash flow | -$297.60M | -$317.75M | -$114.33M | -$192.14M | -$192.89M | -$186.00M | -$184.15M | -$223.69M |
| Depreciation & amortization | $13.27M | $13.30M | $13.16M | $13.09M | $12.71M | $12.87M | $12.46M | $12.64M |
| Stock-based compensation | $5.90M | $5.40M | $5.47M | $6.49M | $5.50M | $5.40M | $5.14M | $6.36M |
| Share buybacks | $226.25M | $206.25M | $206.25M | $143.75M | $218.75M | $218.75M | $218.75M | $212.50M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.